A Rare Case Report of Duodenal Adenocarcinoma Accompanied by Cerebellar Medulloblastoma by Afaghi, Siamak et al.
School of Medicine Students‘ Journal (2020) 2:2 • 23
A Rare Case Report of Duodenal Adenocarcinoma Accompa-
nied by Cerebellar Medulloblastoma
doi:10.22037/smsj.v2i2.29987
Siamak Afagh1, Nastaran Khoshpour2, Amirhossein Hosseini3, Farzad Esmaeili Tarki1, Fatemeh Sadat Rahimi1, Yalda Nilipour4, 
Mohsen Roozrokh5, Naghi Dara3, Negar Imanzadeh6, Ali Akbar Sayyari7*
1- Pediatric Gastroenterology, Hepatology and Nutrition Center, Research Institute for Children’s Health, Shahid Beheshti University of Medical Sciences, Tehran, 
Iran.
2- Department of pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Assistant Professor of Pediatric Gastroenterohepatology, Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Chil-
dren’s Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- Associated professor of pathology, Pediatric Pathology Research center, research institute for children’s health, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran.
5- Professor of Pediatric Surgery, Pediatric Surgery Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, 
Tehran, Iran. 
6- School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
7- Professor of Pediatric Gastroenterohepatology, Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children’s Health, 
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Here is a case of a 6-year-old female with a diagnosis of Duodenal Adenocarcinoma 
presented by the authors, in which 24 months subsequent to radiation therapy for a 
Cerebellar Medulloblastomas the mentioned diagnosis has been confirmed. Although 
the chance of a secondary malignancy has been confirmed to become elevated in 
children formerly undergone radiation therapy, the incidence of duodenal adenocar-
cinoma is a highly infrequent condition. As a consideration, observing manifestations 
like weight loss, vomiting, and icterus in a pediatric patient, who has been administered 
earlier on with radiation therapy, must alert physicians that the risk of a gastrointestinal 
malignancy exists.
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INTRODUCTION
Medulloblastoma, forming about one fifth of all childhood 
brain tumors, is considered as the most prevalent brain ma-
lignancy in pediatric patients [1]. Medulloblastomas in terms 
of cell origin are histologically high-grade embryonal tumors, 
which have been now categorized alongside other embryonal 
tumors under the classification of primitive neuro-ectodermal 
tumors (PNET) [2]. Surgical resection preceded and/or?? fol-
lowed by radiation and chemotherapy is the mainstay of ther-
apy with a five-year survival rate of 75% [3]. Even though the 
small intestine is the longest section of Gastrointestinal (GI) 
tract forming the vastest surface of it, small bowel adenocar-
cinoma (SBA) is quite infrequent [4] which has anincidence 
of fifty times smaller than that of colorectal carcinoma [5]. It 
should be noted that the diagnosis is oftentimes confirmed at an 
advanced stage because of being poorly noticed by radiologic 
imaging ,since  it is  hardly accessible endoscopically, it has 
low suspicion index and late atypic manifestations [6]. These 
factors all usually result in a flawed outcome. On account of 
being a unique GI malignancy,  as rare as it is, evidence asso-
ciated with its optimal management are quite low. The fact that 
two distinct cancers occur simultaneously in an individual has 
been formerly reported in the texts,butthis unique infrequent 
phenomenon mostly regards patients in whom two coinciding 
neoplasms occur simultaneously in the same organ while being 
histologically  distinguished. Here is a report of a 6-year-old 
case with duodenal adenocarcinoma accompanied by Cerebel-
lar Medulloblastoma.
CASE REPORT
Our patient, a 6-year-old female, has right cerebellar hemi-
sphere Medulloblastomas who has been diagnosed at the age 
of four. She has undergone cerebellar radiotherapy, chemo-
therapy and neurosurgery. Soon afterwards, certain sequenc-
ing workups were done for the patient to classify the risk of 
Medulloblastoma, analyzing immunohistochemical markers of 
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atic duct mass and the duodenectomy. Numerous biopsies were 
obtained from the omentum, the mass, and peripheral lymph 
nodes. The report of pathology indicates mucinous adenocarci-
noma arising on villous adenomatous polyp (Figure 2).
DISCUSSION
Being exposed to great dosages of radiation in childhood might 
elevate the chance of second primary tumors progressing after-
wards in life [7]. although the survival rate of pediatric patients 
with primary childhood tumors rise after treatment with radia-
tion therapy, but the possibility to develop secondary malignan-
cies might increase during childhood. Chiefly, respiratory sys-
tem malignancies and hematologic cancers of leukemia’s are 
among these secondary pediatric cancers [8, 9]. Notably, Small 
intestinal adenocarcinoma occurs in highly rare situations. In 
pediatric patients, duodenal cancers represent an even more un-
usual entity [10] despite the fact that the relative risk of devel-
oping intestinal cancer is demonstrated to be notably increased 
following chemotherapy for non-Hodgkin’s lymphoma. The 
relative risk has been larger in cases who have been younger 
at the initial therapy [11]. In one case-series study of 429 cases 
undergone treatment with radiation therapy for pediatric solid 
tumors, 13 (3%) presented a second malignant neoplasm, of 
whom only 1 had developed colon malignancy. Furthermore, to 
the best of our knowledge, there was not any patient reported to 
YAP1, GAP1, and P53, which came out with negative results. 
Approximately nine months after the diagnosis of Medullo-
blastoma, the patient was referred to the hospital complaining 
of bone pain in her left arm. With a suspicion to extra neural 
metastasis of Medulloblastomas, the patient was administered 
with a bone scan diagnostic procedure, which then the primary 
diagnosis was confirmed, and chemotherapy, which had been 
already started before the suspicioned metastasis, was indeed 
continued. After two years, the patient referred to the emergen-
cy department having complaints of fever, anorexia, nausea. 
with pale, icteroid resemblance, her physical examination re-
vealed the abdominal pain with the mild localized tenderness in 
epigastric area. The ultrasonography finding was suggestive of 
the common bile duct (CBD) obstruction. As a temporary mea-
sure, she underwent the surgery of common bile duct dilatation 
and T-tube insertion. Shortly thereafter, she was admitted again 
with icterus, dark urine, nausea, vomiting and diarrhea. She 
was examined with cholangiography, which indicated CBD 
obstruction and dilatation of intrahepatic and extrahepatic bile 
ducts (figure.1). In an evaluation by esophagogastroduodenos-
copy, a large polyp mass with a size of 1.5 cm was spotted in the 
sphincter of Oddi.  moreover, erythematous areas and erosive 
lesions were appeared to be present in the stomach suggesting 
a possible gastritis. A laparotomy surgery was performed on the 
patient, comprising total resection of distracting hepatopancre-
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Figure 1. An upper endoscopy of the patient reported the white spotted involvement of esophagus suggesting candidiasis 
infection. Significant erythematous and erosive parts in the body section of stomach was diagnostic of gastritis. A 1.5 cm 
non-bleeding polypoid mass existed in the location of sphincter of Oddi. The bile fluid was yet to flow due to previous place-
ment of T-tube.
Figure 2. The tissue samples of duodenal adenocarcinoma, undergone hematoxylin and eosin staining, demonstrate poorly-dif-
ferentiated portions of papillary component arising from covering intestinal mucosa of papilla.
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have duodenal adenocarcinoma [12]. Six patients afflicted with 
intestinal adenocarcinoma were found to be reviewed in the 
texts as secondary cancerous neoplasms following the therapy 
for primary tumors. Among these six cases, there was 1 case 
of Wilms’ tumor [13], 2 cases of acute lymphoblastic leuke-
mia [14, 15] and 3 cases of rhabdomyosarcoma [13, 16, 17]. 
Notwithstanding, none of the mentioned adenocarcinomatous 
lesions involved the small duodenum.  notably, Turcot’s syn-
drome has been also taken into account in this case which is 
clinically defined when brain cancers and colon malignancies 
occur in one patient [18]. There are two subtypes to this condi-
tion, both involving germ-line inactivating mutations where for 
type 1 and type 2 the mutations take place in mismatch repair 
gene and APC gene, respectively. Both types show an auto-
somal dominant inheritance pattern, whereas type 1 manifests 
itself mostly in early adulthood [19]. With all mentioned above, 
it could be understood that our case did not meet either of those 
two categories requirements for multiple reasons. To list some, 
the patient was presented at a very young age, she lacked other 
related characteristics like a positive family history and mul-
tiple polyposis, and also other arcane presentations like lupus 
and skin symptoms were present.  Weight loss, vomiting, and 
indistinct abdominal pain are among the most common clinical 
manifestations of childhood gastrointestinal carcinoma. These 
malignancies show particularly poor prognostic features be-
cause the onset of their presentation is quite late in life [20]. 
Keeping that in mind, childhood GI malignancies must be con-
sidered in cases with suspicious abdominal complaints who 
have formerly undergone chemotherapy or radiation therapy 
for prior pediatric cancers. The crux of a proper management 
in these cases is to try to recognize the distinguishing clinical 
and physical features exhibited, even prior to the cancer pre-
senting itself. Therefore, the in-time screening can be notewor-
thy. 
CONCLUSION
In summary, irrespective of the different clarifications, which 
could be mentioned, we described the bizarre simultaneous oc-
currence of both a duodenal adenocarcinoma and a cerebellar 
medulloblastoma. The former malignancy most likely devel-
oped while undergoing previous radiotherapy for the medul-
loblastoma, for the previous24 months. The main rationale be-
hind which we think of radiation as the most probable causal 
element for the progression of the brand-new malignancy, is 
the fact that radiation therapy can explain the development of 
a secondary cancer in multiple other examples. Additionally, 
we better bear in mind, that thus far there has not been any ev-
idence of clinical or histological connection between medullo-
blastoma and adenocarcinoma. Notwithstanding the evidence, 
the chance of a distinct but unexplained genetic imbalance be-
ing responsible for the concomitant development of these two 
tumors cannot be ignored. Further research especially molecu-
lar research is needed to shed light on the matter.
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